DK0628548T3 - 1,2,3,4-Tetraydro-acridinamin-derivater - Google Patents
1,2,3,4-Tetraydro-acridinamin-derivaterInfo
- Publication number
- DK0628548T3 DK0628548T3 DK94112223T DK94112223T DK0628548T3 DK 0628548 T3 DK0628548 T3 DK 0628548T3 DK 94112223 T DK94112223 T DK 94112223T DK 94112223 T DK94112223 T DK 94112223T DK 0628548 T3 DK0628548 T3 DK 0628548T3
- Authority
- DK
- Denmark
- Prior art keywords
- acridinamine
- derivatives
- tetraydro
- agents
- cerebral
- Prior art date
Links
- 208000024827 Alzheimer disease Diseases 0.000 abstract 2
- 230000002490 cerebral effect Effects 0.000 abstract 2
- 208000023105 Huntington disease Diseases 0.000 abstract 1
- 206010020651 Hyperkinesia Diseases 0.000 abstract 1
- 208000000269 Hyperkinesis Diseases 0.000 abstract 1
- 206010026749 Mania Diseases 0.000 abstract 1
- 206010039966 Senile dementia Diseases 0.000 abstract 1
- 206010043118 Tardive Dyskinesia Diseases 0.000 abstract 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 abstract 1
- 229960004373 acetylcholine Drugs 0.000 abstract 1
- 239000000730 antalgic agent Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- YLJREFDVOIBQDA-UHFFFAOYSA-N tacrine Chemical class C1=CC=C2C(N)=C(CCCC3)C3=NC2=C1 YLJREFDVOIBQDA-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/08—Nitrogen atoms
- C07D219/10—Nitrogen atoms attached in position 9
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Psychiatry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Water Treatment By Electricity Or Magnetism (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/387,722 US4999430A (en) | 1989-07-31 | 1989-07-31 | Derivatives of 1,2,3,4-tetrahydro-9-acrisinamine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0628548T3 true DK0628548T3 (da) | 2000-05-08 |
Family
ID=23531113
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK90114586.2T DK0411534T3 (da) | 1989-07-31 | 1990-07-30 | Derivater af 1,2,3,4-tetrahydro-9-acridinamin |
| DK94112223T DK0628548T3 (da) | 1989-07-31 | 1990-07-30 | 1,2,3,4-Tetraydro-acridinamin-derivater |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK90114586.2T DK0411534T3 (da) | 1989-07-31 | 1990-07-30 | Derivater af 1,2,3,4-tetrahydro-9-acridinamin |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4999430A (da) |
| EP (2) | EP0628548B1 (da) |
| JP (1) | JP2930245B2 (da) |
| KR (1) | KR910002802A (da) |
| AT (2) | ATE186908T1 (da) |
| AU (1) | AU5994590A (da) |
| CA (1) | CA2022297C (da) |
| DE (2) | DE69017789T2 (da) |
| DK (2) | DK0411534T3 (da) |
| ES (2) | ES2068955T3 (da) |
| FI (1) | FI903752A7 (da) |
| GR (1) | GR3032539T3 (da) |
| IE (1) | IE66823B1 (da) |
| NO (1) | NO903359L (da) |
| NZ (1) | NZ234672A (da) |
| PT (1) | PT94849A (da) |
| ZA (1) | ZA905978B (da) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH25124A (en) * | 1987-03-17 | 1991-02-19 | Hoechst Roussel Pharma | Substituted 9-amino-tetrahydro acridines and related compounds |
| FR2640508B1 (fr) * | 1988-12-19 | 1994-07-01 | Dietlin Francois | Nouvelles compositions et nouveaux produits pharmaceutiques assurant la regeneration de leucocytes et leur emploi pour le traitement du syndrome immuno-deficitaire |
| CA2029497C (en) * | 1989-11-08 | 2002-06-04 | Kunihiro Ninomiya (Deceased) | 4-acylaminopyridine derivative |
| JP2546919B2 (ja) * | 1989-11-08 | 1996-10-23 | 三菱化学株式会社 | 9ーアシルアミノテトラヒドロアクリジン誘導体 |
| US5179100A (en) * | 1992-03-09 | 1993-01-12 | Hoechst-Roussel Pharmaceuticals Inc. | 4,5-dihydropyrazolo[3,4-a]acridines |
| US5466696A (en) * | 1992-09-10 | 1995-11-14 | Warner Lambert Company | Tacrine and cytochrome P450 oxidase inhibitors and methods of use |
| US5422350A (en) * | 1992-09-10 | 1995-06-06 | Warner-Lambert Company | Nitrogen substituted acridine and cytochrome P450 inhibitors and methods of use |
| HU213107B (en) * | 1994-02-23 | 1997-02-28 | Egyt Gyogyszervegyeszeti Gyar | Process for producing acetic acid derivatives and pharmaceutical compositions containing them |
| GB9716879D0 (en) * | 1997-08-08 | 1997-10-15 | Shire Int Licensing Bv | Treatment of attention deficit disorders |
| US6218383B1 (en) | 1998-08-07 | 2001-04-17 | Targacept, Inc. | Pharmaceutical compositions for the prevention and treatment of central nervous system disorders |
| ES2168926B1 (es) * | 1999-12-14 | 2003-10-16 | Prous Science S A | Derivados de ciclopenta- ciclohexa- y ciclohepta (b)quinoleina, procedimiento para su fabricacion, utilizacion y composicion farmaceutica correspondiente. |
| EP1779867A4 (en) * | 2004-07-01 | 2009-12-02 | Eisai R&D Man Co Ltd | MEANS FOR PROMOTING NERVE REVENERATION |
| CN1315810C (zh) * | 2004-08-30 | 2007-05-16 | 北京理工大学 | 哌嗪桥联他克林双体衍生物及其合成方法 |
| US20080188510A1 (en) * | 2005-05-23 | 2008-08-07 | Eisai R & D Management Co., Ltd. | Novel methods using zonisamide |
| CN103180297A (zh) * | 2009-12-11 | 2013-06-26 | 基因密码公司 | 使用gdnf家族配体(gfl)模拟剂或ret信号传导通路活化剂促进神经细胞存活的方法 |
| EA202092673A3 (ru) | 2010-02-09 | 2021-05-31 | Дзе Джонс Хопкинс Юниверсити | Способы и композиции для улучшения когнитивной функции |
| US20140206667A1 (en) | 2012-11-14 | 2014-07-24 | Michela Gallagher | Methods and compositions for treating schizophrenia |
| WO2014144663A1 (en) | 2013-03-15 | 2014-09-18 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| AU2014228512A1 (en) | 2013-03-15 | 2015-10-01 | Agenebio, Inc. | Methods and compositions for improving cognitive function |
| CA2986598C (en) | 2015-05-22 | 2023-09-26 | Agenebio, Inc. | Extended release pharmaceutical compositions of levetiracetam |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3889302T2 (de) * | 1987-12-03 | 1994-10-20 | Mitsubishi Chem Ind | 9-(Acylamino)tetrahydroacridinderivate und wahrnehmungssteigernde Mittel davon als aktiver Wirkstoff. |
-
1989
- 1989-07-31 US US07/387,722 patent/US4999430A/en not_active Expired - Lifetime
-
1990
- 1990-07-27 AU AU59945/90A patent/AU5994590A/en not_active Abandoned
- 1990-07-27 NZ NZ234672A patent/NZ234672A/xx unknown
- 1990-07-27 FI FI903752A patent/FI903752A7/fi not_active Application Discontinuation
- 1990-07-30 ZA ZA905978A patent/ZA905978B/xx unknown
- 1990-07-30 JP JP2199361A patent/JP2930245B2/ja not_active Expired - Fee Related
- 1990-07-30 AT AT94112223T patent/ATE186908T1/de not_active IP Right Cessation
- 1990-07-30 KR KR1019900011578A patent/KR910002802A/ko not_active Withdrawn
- 1990-07-30 AT AT90114586T patent/ATE119885T1/de not_active IP Right Cessation
- 1990-07-30 ES ES90114586T patent/ES2068955T3/es not_active Expired - Lifetime
- 1990-07-30 EP EP94112223A patent/EP0628548B1/en not_active Expired - Lifetime
- 1990-07-30 DK DK90114586.2T patent/DK0411534T3/da active
- 1990-07-30 CA CA002022297A patent/CA2022297C/en not_active Expired - Fee Related
- 1990-07-30 NO NO90903359A patent/NO903359L/no unknown
- 1990-07-30 DK DK94112223T patent/DK0628548T3/da active
- 1990-07-30 IE IE275190A patent/IE66823B1/en not_active IP Right Cessation
- 1990-07-30 ES ES94112223T patent/ES2141787T3/es not_active Expired - Lifetime
- 1990-07-30 DE DE69017789T patent/DE69017789T2/de not_active Expired - Fee Related
- 1990-07-30 EP EP90114586A patent/EP0411534B1/en not_active Expired - Lifetime
- 1990-07-30 PT PT94849A patent/PT94849A/pt not_active Application Discontinuation
- 1990-07-30 DE DE69033369T patent/DE69033369T2/de not_active Expired - Fee Related
-
2000
- 2000-02-02 GR GR20000400235T patent/GR3032539T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69017789D1 (de) | 1995-04-20 |
| EP0628548B1 (en) | 1999-11-24 |
| NO903359L (no) | 1991-02-01 |
| DE69033369T2 (de) | 2000-05-11 |
| IE902751A1 (en) | 1991-02-27 |
| JPH0366670A (ja) | 1991-03-22 |
| DE69017789T2 (de) | 1995-07-13 |
| CA2022297C (en) | 2001-09-18 |
| GR3032539T3 (en) | 2000-05-31 |
| ATE186908T1 (de) | 1999-12-15 |
| DK0411534T3 (da) | 1995-07-24 |
| EP0411534A2 (en) | 1991-02-06 |
| KR910002802A (ko) | 1991-02-26 |
| EP0628548A1 (en) | 1994-12-14 |
| US4999430A (en) | 1991-03-12 |
| ES2068955T3 (es) | 1995-05-01 |
| PT94849A (pt) | 1991-04-18 |
| FI903752A7 (fi) | 1991-02-01 |
| NO903359D0 (no) | 1990-07-30 |
| IE66823B1 (en) | 1996-02-07 |
| ATE119885T1 (de) | 1995-04-15 |
| ZA905978B (en) | 1992-04-29 |
| EP0411534B1 (en) | 1995-03-15 |
| ES2141787T3 (es) | 2000-04-01 |
| CA2022297A1 (en) | 1991-02-01 |
| FI903752A0 (fi) | 1990-07-27 |
| AU5994590A (en) | 1991-01-31 |
| DE69033369D1 (de) | 1999-12-30 |
| NZ234672A (en) | 1991-11-26 |
| JP2930245B2 (ja) | 1999-08-03 |
| EP0411534A3 (en) | 1991-06-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0628548T3 (da) | 1,2,3,4-Tetraydro-acridinamin-derivater | |
| IT1229203B (it) | Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative. | |
| FI904204A0 (fi) | Foerfarande foer framstaellning av cykliska aminosyraderivat och mellanprodukter. | |
| ZA906057B (en) | 4-(n-substituted amino)-2-butynyl-1-ureas and thioureas and derivatives thereof as centrally acting muscarinic agents | |
| FI900365A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 3-fenyyli-5,6-dihydrobents/C/akridiini-7-karboksyylihappojohdannnaisten valmistamiseksi | |
| AU653802B2 (en) | Condensed diazepinones | |
| ES2009689A6 (es) | Procedimiento para preparar derivados de 3-piperidina-carbaldehido-oxima. | |
| NO177145C (no) | Analogifremgangsmåte for fremstilling av 4,5,6,7-tetrahydroisotiazolo[4,5-cÅ-pyridinderivater og isomere | |
| EP0276805A3 (en) | Substituted 3-phenyl-7h-thiazoloû3,2-b¨û1,2,4¨triazin-7-ones, processes for their preparation, medicaments containing them and their use as well as some of the intermediates obtained during the preparation of said compounds | |
| ES2008421A6 (es) | Procedimiento para la obtencion de derivados de la pilocarpina. |